CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 116 enrolled
Drug / intervention
Atorvastatin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02056340
NCT02056340Phase 2Completed

Statin Therapy in Acute Influenza

Beth Israel Deaconess Medical Center·interventional·Posted Feb 6, 2014·Updated Jul 26, 2019

In Brief

A Phase 2 clinical trial evaluating Atorvastatin and Placebo for Influenza. Completed, enrolled 116 participants across 1 site.

Detailed Summary

Influenza (the 'flu') is a common virus infecting approximately 5-20% of the population in the United States and causing as many as 500,000 deaths worldwide each year. Currently, there are only a few treatments for influenza infection and none of these target inflammation that can be caused by the virus. This study will test whether the anti-inflammatory effects of statins, a class of drugs most often used to treat high cholesterol, will decrease the severity of illness in patients who are infected with influenza by testing markers of inflammation in the blood and recording resolution of influenza illness.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsInfluenza
CountriesUnited States

Timeline

Phase 2CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedFeb 6, 2014
Enrollment StartOct 1, 2013
Primary CompletionJun 30, 2018
TodayJul 2, 2026
Enrollment to primary: 4.7 yearsPosted 12.4 years ago

Interventions

Atorvastatindrug

Placebodrug